Articles by Melanie Sena - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Melanie Sena

Vetter Implements New Serialization Services

Mar 28, 2014

Vetter launches new serialization process to support track-and-trace efforts.

XstalBio Launches Vaccine Analysis Service

Mar 24, 2014

XstalBio Analytics' approach to vaccine analysis and formulation is aimed at understanding the antigen– adjuvant interaction.

FDA approves Novartis' Xolair for Rare Skin Disease

Mar 24, 2014

FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.

Texas A&M Center Adds Mobile Cleanrooms

Mar 13, 2014

Walker Barrier Systems builds eight mobile clean rooms for the Texas A&M Center for Innovation in Advanced Development and Manufacturing.

Almac Expands Asia Pacific Operations

Mar 12, 2014

Almac expands technical, project, and operational resources in Asia.

DPx Launched as Provider of Pharmaceutical Services, Fine Chemicals, and Proprietary Technologies

Mar 12, 2014

$2.6 billion transaction combines Patheon and DSM Pharmaceutical to create CDMO, DPx.

Johnson Controls Launches Integrated Laboratory Services

Mar 7, 2014

Johnson Controls launches Integrated Laboratory Services for R&D facility operations and scientific productivity.

Cobra Biologics and BioCancell Collaborate on Cancer Therapy Drug

Mar 7, 2014

Cobra Biologics and BioCancell announce an agreement to manufacture BioCancell's BC-821 cancer drug.

CPhI Report Shows R&D Market Diversifying

Mar 7, 2014

CPhI report shows R&D market diversifying with increased partnerships, mergers, and revenue sharing models.

ADVERTISEMENT

ADVERTISEMENT

Click here